Northwest Biotherapeutics Shares Trade Lower Following Seeking Alpha Article

Loading...
Loading...
Shares of Northwest Biotherapeutics, Inc
NWBO
trade lower by nearly 8.82 percent after activist investor, Richard Pearson released a
bearish article
on Seeking Alpha stating the stock has been inflated by the company's promotional efforts, utilizing ties with MDM Worldwide and Redfish Creative to publish positive news on the company that Pearson claims was misleading to investors. Pearson cited that in the writings of promotional articles, the firm Redfish Creative used bulk pricing on Northwest Bio, with mass message postings on Yahoos comment board. Other incidents were reported with the company's promotional efforts, for example reports of paid authors using fake credentials in healthcare or finance, along with made up identities. Similar claims were reported in June 19th
article
published by The Street author Adam Feuerstein. The Street article titled ‘Prestigious Cancer Hospital Rebukes Northwest Bio for 'Inappropriate' Data Disclosures,' stated in Northwest Biotherapeutics promotional efforts, the company made unjustifiable claims in relation to DCVax-Direct, cancer vaccine. The stock traded lower following Feuerstein's article on June 19, by 1.79 percent.
Posted In: NewsMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...